Arecor Therapeutics plc (AREC.L)
GBp 38.0
(0.0%)
GBp 38.0
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.28 GBP | 12.5% |
| 2022 | -0.32 GBP | -18.52% |
| 2021 | -0.27 GBP | -171.63% |
| 2020 | -0.10 GBP | 29.0% |
| 2019 | -0.14 GBP | -59.09% |
| 2018 | -0.09 GBP | -117.82% |
| 2017 | -0.04 GBP | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.08 GBP | 0.0% |
| 2024 Q1 | -0.08 GBP | -15.37% |
| 2023 Q4 | -0.07 GBP | 0.0% |
| 2023 FY | - GBP | 12.5% |
| 2023 Q2 | -0.15 GBP | -102.98% |
| 2023 Q3 | -0.07 GBP | 56.2% |
| 2023 Q1 | -0.07 GBP | 53.81% |
| 2022 Q2 | -0.16 GBP | -104.08% |
| 2022 Q1 | -0.08 GBP | 28.73% |
| 2022 Q4 | -0.16 GBP | -96.56% |
| 2022 FY | - GBP | -18.52% |
| 2022 Q3 | -0.08 GBP | 49.13% |
| 2021 Q3 | -0.06 GBP | 50.0% |
| 2021 Q2 | -0.11 GBP | -29.11% |
| 2021 FY | - GBP | -171.63% |
| 2021 Q1 | -0.09 GBP | -38.31% |
| 2021 Q4 | -0.11 GBP | -100.0% |
| 2020 Q3 | -0.05 GBP | -38.36% |
| 2020 Q2 | -0.04 GBP | -17.03% |
| 2020 Q1 | -0.03 GBP | 0.0% |
| 2020 FY | - GBP | 29.0% |
| 2020 Q4 | -0.06 GBP | -17.78% |
| 2019 FY | - GBP | -59.09% |
| 2018 FY | - GBP | -117.82% |
| 2017 FY | - GBP | 0.0% |
| Name | Eps | Eps Difference |
|---|